Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Income from Continuing Operations of 57000.0 for Q4 2025, up 101.8% year-over-year from 28245.66 in Q4 2024, and down 95.64% quarter-over-quarter from 1308000.0 in Q3 2025.
Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Income from Continuing Operations for 16 consecutive years, with 57000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Income from Continuing Operations rose 101.8% year-over-year to 57000.0; the TTM figure through Dec 2025 stood at 4973000.0 (up 130.23% YoY), while the FY2025 annual figure was 4973000.0, up 130.23% from the prior year.
- Income from Continuing Operations declined to 57000.0 in Q4 2025 per XTNT's latest filing, from 1308000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 9231000.0 in Q3 2023 and bottomed at 6204000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 1251700.0 across 5 years, with a median of 1941000.0 in 2021.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 7531.03% — and 2023, when it soared 492.31%.
- Xtant Medical Holdings' Income from Continuing Operations stood at 1265000.0 in 2021, then sank by 74.62% to 2209000.0 in 2022, then tumbled by 180.85% to 6204000.0 in 2023, then soared by 48.98% to 3165000.0 in 2024, then surged by 101.8% to 57000.0 in 2025.
- Business Quant data shows XTNT's Income from Continuing Operations at 57000.0 in Q4 2025, 1308000.0 in Q3 2025, and 3550000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Xtant Medical Holdings | 46.53 Mn | 28.93 Mn | 17.75 Mn | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | -3.17 Mn |
| Sep 30, 2024 | -5.02 Mn |
| Jun 30, 2024 | -3.86 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -6.20 Mn |
| Sep 30, 2023 | 9.23 Mn |
| Jun 30, 2023 | -2.19 Mn |
| Mar 31, 2023 | -2.08 Mn |
| Dec 31, 2022 | -2.21 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Jun 30, 2022 | -1.71 Mn |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -733,000.00 |
| Mar 31, 2021 | -29,000.00 |